nodes	percent_of_prediction	percent_of_DWPC	metapath
Acetazolamide—AQP1—seminal vesicle—testicular cancer	0.0146	0.146	CbGeAlD
Acetazolamide—CA14—seminal vesicle—testicular cancer	0.00971	0.0975	CbGeAlD
Acetazolamide—AQP1—female gonad—testicular cancer	0.00857	0.086	CbGeAlD
Acetazolamide—AQP1—testis—testicular cancer	0.0076	0.0762	CbGeAlD
Acetazolamide—CA3—testis—testicular cancer	0.00557	0.0559	CbGeAlD
Acetazolamide—AQP1—lymph node—testicular cancer	0.00551	0.0553	CbGeAlD
Acetazolamide—CA9—testis—testicular cancer	0.00533	0.0535	CbGeAlD
Acetazolamide—CA5B—gonad—testicular cancer	0.00491	0.0493	CbGeAlD
Acetazolamide—CA4—seminal vesicle—testicular cancer	0.00469	0.0471	CbGeAlD
Acetazolamide—CA2—embryo—testicular cancer	0.00414	0.0416	CbGeAlD
Acetazolamide—CA3—lymph node—testicular cancer	0.00404	0.0405	CbGeAlD
Acetazolamide—CA2—seminal vesicle—testicular cancer	0.00389	0.039	CbGeAlD
Acetazolamide—CA5B—testis—testicular cancer	0.00354	0.0355	CbGeAlD
Acetazolamide—Fatigue—Chlorambucil—testicular cancer	0.00284	0.00315	CcSEcCtD
Acetazolamide—Melaena—Methotrexate—testicular cancer	0.00282	0.00313	CcSEcCtD
Acetazolamide—Malaise—Bleomycin—testicular cancer	0.00281	0.00312	CcSEcCtD
Acetazolamide—Leukopenia—Bleomycin—testicular cancer	0.00279	0.0031	CcSEcCtD
Acetazolamide—Hepatobiliary disease—Cisplatin—testicular cancer	0.00278	0.00309	CcSEcCtD
Acetazolamide—CA4—female gonad—testicular cancer	0.00275	0.0276	CbGeAlD
Acetazolamide—Feeling abnormal—Chlorambucil—testicular cancer	0.00271	0.00301	CcSEcCtD
Acetazolamide—Aplastic anaemia—Methotrexate—testicular cancer	0.00271	0.00301	CcSEcCtD
Acetazolamide—Paraesthesia—Vinblastine—testicular cancer	0.00271	0.00301	CcSEcCtD
Acetazolamide—Ill-defined disorder—Dactinomycin—testicular cancer	0.0027	0.003	CcSEcCtD
Acetazolamide—Stevens-Johnson syndrome—Etoposide—testicular cancer	0.00267	0.00297	CcSEcCtD
Acetazolamide—Melaena—Epirubicin—testicular cancer	0.00264	0.00293	CcSEcCtD
Acetazolamide—Discomfort—Bleomycin—testicular cancer	0.00262	0.00291	CcSEcCtD
Acetazolamide—Malaise—Dactinomycin—testicular cancer	0.00262	0.00291	CcSEcCtD
Acetazolamide—Decreased appetite—Vinblastine—testicular cancer	0.00262	0.00291	CcSEcCtD
Acetazolamide—Urticaria—Chlorambucil—testicular cancer	0.00261	0.0029	CcSEcCtD
Acetazolamide—Urine output increased—Methotrexate—testicular cancer	0.00261	0.0029	CcSEcCtD
Acetazolamide—Leukopenia—Dactinomycin—testicular cancer	0.0026	0.00289	CcSEcCtD
Acetazolamide—Body temperature increased—Chlorambucil—testicular cancer	0.0026	0.00289	CcSEcCtD
Acetazolamide—Confusional state—Bleomycin—testicular cancer	0.00257	0.00285	CcSEcCtD
Acetazolamide—CA5B—lymph node—testicular cancer	0.00257	0.0257	CbGeAlD
Acetazolamide—Hepatobiliary disease—Etoposide—testicular cancer	0.00255	0.00283	CcSEcCtD
Acetazolamide—Anaphylactic shock—Bleomycin—testicular cancer	0.00255	0.00283	CcSEcCtD
Acetazolamide—Aplastic anaemia—Epirubicin—testicular cancer	0.00253	0.00282	CcSEcCtD
Acetazolamide—Agranulocytosis—Etoposide—testicular cancer	0.00251	0.00279	CcSEcCtD
Acetazolamide—Thrombocytopenia—Bleomycin—testicular cancer	0.00249	0.00277	CcSEcCtD
Acetazolamide—Feeling abnormal—Vinblastine—testicular cancer	0.00248	0.00276	CcSEcCtD
Acetazolamide—Ill-defined disorder—Ifosfamide—testicular cancer	0.00247	0.00275	CcSEcCtD
Acetazolamide—Tinnitus—Cisplatin—testicular cancer	0.00246	0.00273	CcSEcCtD
Acetazolamide—Flushing—Cisplatin—testicular cancer	0.00245	0.00272	CcSEcCtD
Acetazolamide—Agitation—Ifosfamide—testicular cancer	0.00245	0.00272	CcSEcCtD
Acetazolamide—Discomfort—Dactinomycin—testicular cancer	0.00245	0.00272	CcSEcCtD
Acetazolamide—CA4—testis—testicular cancer	0.00244	0.0245	CbGeAlD
Acetazolamide—Melaena—Doxorubicin—testicular cancer	0.00244	0.00271	CcSEcCtD
Acetazolamide—Hypoaesthesia—Etoposide—testicular cancer	0.00241	0.00267	CcSEcCtD
Acetazolamide—Malaise—Ifosfamide—testicular cancer	0.0024	0.00267	CcSEcCtD
Acetazolamide—Leukopenia—Ifosfamide—testicular cancer	0.00239	0.00265	CcSEcCtD
Acetazolamide—Photosensitivity—Methotrexate—testicular cancer	0.00239	0.00265	CcSEcCtD
Acetazolamide—Polyuria—Methotrexate—testicular cancer	0.00239	0.00265	CcSEcCtD
Acetazolamide—Asthenia—Chlorambucil—testicular cancer	0.00236	0.00262	CcSEcCtD
Acetazolamide—Aplastic anaemia—Doxorubicin—testicular cancer	0.00235	0.00261	CcSEcCtD
Acetazolamide—Hepatic failure—Methotrexate—testicular cancer	0.00233	0.00259	CcSEcCtD
Acetazolamide—Thrombocytopenia—Dactinomycin—testicular cancer	0.00232	0.00258	CcSEcCtD
Acetazolamide—Convulsion—Ifosfamide—testicular cancer	0.00231	0.00257	CcSEcCtD
Acetazolamide—Erythema multiforme—Etoposide—testicular cancer	0.00229	0.00254	CcSEcCtD
Acetazolamide—Paraesthesia—Bleomycin—testicular cancer	0.00229	0.00254	CcSEcCtD
Acetazolamide—CA2—female gonad—testicular cancer	0.00228	0.0229	CbGeAlD
Acetazolamide—CA1—lymph node—testicular cancer	0.00227	0.0227	CbGeAlD
Acetazolamide—Diarrhoea—Chlorambucil—testicular cancer	0.00225	0.0025	CcSEcCtD
Acetazolamide—Flushing—Etoposide—testicular cancer	0.00224	0.00249	CcSEcCtD
Acetazolamide—Hepatic function abnormal—Epirubicin—testicular cancer	0.00224	0.00249	CcSEcCtD
Acetazolamide—Discomfort—Ifosfamide—testicular cancer	0.00224	0.00249	CcSEcCtD
Acetazolamide—Photosensitivity—Epirubicin—testicular cancer	0.00223	0.00248	CcSEcCtD
Acetazolamide—Decreased appetite—Bleomycin—testicular cancer	0.00221	0.00246	CcSEcCtD
Acetazolamide—Confusional state—Ifosfamide—testicular cancer	0.00219	0.00244	CcSEcCtD
Acetazolamide—Hepatic failure—Epirubicin—testicular cancer	0.00218	0.00242	CcSEcCtD
Acetazolamide—Anaphylactic shock—Ifosfamide—testicular cancer	0.00218	0.00242	CcSEcCtD
Acetazolamide—Anaphylactoid reaction—Methotrexate—testicular cancer	0.00216	0.0024	CcSEcCtD
Acetazolamide—Asthenia—Vinblastine—testicular cancer	0.00216	0.0024	CcSEcCtD
Acetazolamide—Ill-defined disorder—Cisplatin—testicular cancer	0.00213	0.00237	CcSEcCtD
Acetazolamide—Thrombocytopenia—Ifosfamide—testicular cancer	0.00213	0.00237	CcSEcCtD
Acetazolamide—Feeling abnormal—Bleomycin—testicular cancer	0.0021	0.00233	CcSEcCtD
Acetazolamide—Vomiting—Chlorambucil—testicular cancer	0.00209	0.00232	CcSEcCtD
Acetazolamide—Hepatic function abnormal—Doxorubicin—testicular cancer	0.00208	0.0023	CcSEcCtD
Acetazolamide—Malaise—Cisplatin—testicular cancer	0.00207	0.0023	CcSEcCtD
Acetazolamide—Photosensitivity—Doxorubicin—testicular cancer	0.00207	0.00229	CcSEcCtD
Acetazolamide—Decreased appetite—Dactinomycin—testicular cancer	0.00206	0.00229	CcSEcCtD
Acetazolamide—Diarrhoea—Vinblastine—testicular cancer	0.00206	0.00229	CcSEcCtD
Acetazolamide—Dysgeusia—Etoposide—testicular cancer	0.00206	0.00229	CcSEcCtD
Acetazolamide—Leukopenia—Cisplatin—testicular cancer	0.00206	0.00229	CcSEcCtD
Acetazolamide—Fatigue—Dactinomycin—testicular cancer	0.00205	0.00227	CcSEcCtD
Acetazolamide—CA2—testis—testicular cancer	0.00203	0.0203	CbGeAlD
Acetazolamide—Anaphylactoid reaction—Epirubicin—testicular cancer	0.00202	0.00225	CcSEcCtD
Acetazolamide—Urticaria—Bleomycin—testicular cancer	0.00202	0.00225	CcSEcCtD
Acetazolamide—Hepatic failure—Doxorubicin—testicular cancer	0.00202	0.00224	CcSEcCtD
Acetazolamide—Body temperature increased—Bleomycin—testicular cancer	0.00201	0.00224	CcSEcCtD
Acetazolamide—Hypoglycaemia—Epirubicin—testicular cancer	0.00201	0.00223	CcSEcCtD
Acetazolamide—Irritability—Methotrexate—testicular cancer	0.002	0.00222	CcSEcCtD
Acetazolamide—Dizziness—Vinblastine—testicular cancer	0.00199	0.00221	CcSEcCtD
Acetazolamide—Convulsion—Cisplatin—testicular cancer	0.00199	0.00221	CcSEcCtD
Acetazolamide—Ataxia—Methotrexate—testicular cancer	0.00197	0.00219	CcSEcCtD
Acetazolamide—Hyponatraemia—Epirubicin—testicular cancer	0.00197	0.00219	CcSEcCtD
Acetazolamide—Feeling abnormal—Dactinomycin—testicular cancer	0.00196	0.00217	CcSEcCtD
Acetazolamide—Nausea—Chlorambucil—testicular cancer	0.00195	0.00217	CcSEcCtD
Acetazolamide—Paraesthesia—Ifosfamide—testicular cancer	0.00195	0.00217	CcSEcCtD
Acetazolamide—Ill-defined disorder—Etoposide—testicular cancer	0.00195	0.00217	CcSEcCtD
Acetazolamide—Somnolence—Ifosfamide—testicular cancer	0.00193	0.00215	CcSEcCtD
Acetazolamide—Discomfort—Cisplatin—testicular cancer	0.00193	0.00215	CcSEcCtD
Acetazolamide—Vomiting—Vinblastine—testicular cancer	0.00192	0.00213	CcSEcCtD
Acetazolamide—Malaise—Etoposide—testicular cancer	0.0019	0.00211	CcSEcCtD
Acetazolamide—Decreased appetite—Ifosfamide—testicular cancer	0.00189	0.0021	CcSEcCtD
Acetazolamide—Headache—Vinblastine—testicular cancer	0.00189	0.0021	CcSEcCtD
Acetazolamide—Toxic epidermal necrolysis—Methotrexate—testicular cancer	0.00189	0.00209	CcSEcCtD
Acetazolamide—Leukopenia—Etoposide—testicular cancer	0.00188	0.00209	CcSEcCtD
Acetazolamide—Gastrointestinal disorder—Ifosfamide—testicular cancer	0.00188	0.00209	CcSEcCtD
Acetazolamide—Body temperature increased—Dactinomycin—testicular cancer	0.00188	0.00208	CcSEcCtD
Acetazolamide—Fatigue—Ifosfamide—testicular cancer	0.00188	0.00208	CcSEcCtD
Acetazolamide—Anaphylactic shock—Cisplatin—testicular cancer	0.00188	0.00208	CcSEcCtD
Acetazolamide—Anaphylactoid reaction—Doxorubicin—testicular cancer	0.00187	0.00208	CcSEcCtD
Acetazolamide—Hypoglycaemia—Doxorubicin—testicular cancer	0.00186	0.00206	CcSEcCtD
Acetazolamide—Ataxia—Epirubicin—testicular cancer	0.00184	0.00205	CcSEcCtD
Acetazolamide—Thrombocytopenia—Cisplatin—testicular cancer	0.00184	0.00204	CcSEcCtD
Acetazolamide—Asthenia—Bleomycin—testicular cancer	0.00183	0.00203	CcSEcCtD
Acetazolamide—Convulsion—Etoposide—testicular cancer	0.00182	0.00203	CcSEcCtD
Acetazolamide—Hyponatraemia—Doxorubicin—testicular cancer	0.00182	0.00202	CcSEcCtD
Acetazolamide—Feeling abnormal—Ifosfamide—testicular cancer	0.00179	0.00199	CcSEcCtD
Acetazolamide—Nausea—Vinblastine—testicular cancer	0.00179	0.00199	CcSEcCtD
Acetazolamide—Hypokalaemia—Epirubicin—testicular cancer	0.00178	0.00198	CcSEcCtD
Acetazolamide—Discomfort—Etoposide—testicular cancer	0.00177	0.00197	CcSEcCtD
Acetazolamide—CA4—lymph node—testicular cancer	0.00177	0.0178	CbGeAlD
Acetazolamide—Toxic epidermal necrolysis—Epirubicin—testicular cancer	0.00176	0.00196	CcSEcCtD
Acetazolamide—Confusional state—Etoposide—testicular cancer	0.00173	0.00192	CcSEcCtD
Acetazolamide—Urticaria—Ifosfamide—testicular cancer	0.00173	0.00192	CcSEcCtD
Acetazolamide—Body temperature increased—Ifosfamide—testicular cancer	0.00172	0.00191	CcSEcCtD
Acetazolamide—Anaphylactic shock—Etoposide—testicular cancer	0.00172	0.00191	CcSEcCtD
Acetazolamide—Ataxia—Doxorubicin—testicular cancer	0.00171	0.00189	CcSEcCtD
Acetazolamide—Asthenia—Dactinomycin—testicular cancer	0.0017	0.00189	CcSEcCtD
Acetazolamide—Paraesthesia—Cisplatin—testicular cancer	0.00168	0.00187	CcSEcCtD
Acetazolamide—Thrombocytopenia—Etoposide—testicular cancer	0.00168	0.00187	CcSEcCtD
Acetazolamide—Photosensitivity reaction—Methotrexate—testicular cancer	0.00165	0.00184	CcSEcCtD
Acetazolamide—Hypokalaemia—Doxorubicin—testicular cancer	0.00165	0.00183	CcSEcCtD
Acetazolamide—Toxic epidermal necrolysis—Doxorubicin—testicular cancer	0.00163	0.00181	CcSEcCtD
Acetazolamide—Decreased appetite—Cisplatin—testicular cancer	0.00163	0.00181	CcSEcCtD
Acetazolamide—Diarrhoea—Dactinomycin—testicular cancer	0.00162	0.0018	CcSEcCtD
Acetazolamide—Gastrointestinal disorder—Cisplatin—testicular cancer	0.00162	0.0018	CcSEcCtD
Acetazolamide—Vomiting—Bleomycin—testicular cancer	0.00162	0.0018	CcSEcCtD
Acetazolamide—Drowsiness—Methotrexate—testicular cancer	0.00161	0.00179	CcSEcCtD
Acetazolamide—Stevens-Johnson syndrome—Methotrexate—testicular cancer	0.0016	0.00178	CcSEcCtD
Acetazolamide—Asthenia—Ifosfamide—testicular cancer	0.00156	0.00173	CcSEcCtD
Acetazolamide—Photosensitivity reaction—Epirubicin—testicular cancer	0.00155	0.00172	CcSEcCtD
Acetazolamide—Feeling abnormal—Cisplatin—testicular cancer	0.00155	0.00172	CcSEcCtD
Acetazolamide—Paraesthesia—Etoposide—testicular cancer	0.00154	0.00171	CcSEcCtD
Acetazolamide—Haematuria—Methotrexate—testicular cancer	0.00154	0.00171	CcSEcCtD
Acetazolamide—Somnolence—Etoposide—testicular cancer	0.00153	0.0017	CcSEcCtD
Acetazolamide—Hepatobiliary disease—Methotrexate—testicular cancer	0.00153	0.0017	CcSEcCtD
Acetazolamide—Nausea—Bleomycin—testicular cancer	0.00151	0.00168	CcSEcCtD
Acetazolamide—Drowsiness—Epirubicin—testicular cancer	0.00151	0.00168	CcSEcCtD
Acetazolamide—Vomiting—Dactinomycin—testicular cancer	0.00151	0.00168	CcSEcCtD
Acetazolamide—Agranulocytosis—Methotrexate—testicular cancer	0.00151	0.00167	CcSEcCtD
Acetazolamide—Stevens-Johnson syndrome—Epirubicin—testicular cancer	0.0015	0.00166	CcSEcCtD
Acetazolamide—Decreased appetite—Etoposide—testicular cancer	0.00149	0.00166	CcSEcCtD
Acetazolamide—Diarrhoea—Ifosfamide—testicular cancer	0.00149	0.00165	CcSEcCtD
Acetazolamide—Gastrointestinal disorder—Etoposide—testicular cancer	0.00148	0.00165	CcSEcCtD
Acetazolamide—Body temperature increased—Cisplatin—testicular cancer	0.00148	0.00165	CcSEcCtD
Acetazolamide—Fatigue—Etoposide—testicular cancer	0.00148	0.00165	CcSEcCtD
Acetazolamide—CA2—lymph node—testicular cancer	0.00147	0.0147	CbGeAlD
Acetazolamide—Haematuria—Epirubicin—testicular cancer	0.00144	0.0016	CcSEcCtD
Acetazolamide—Dizziness—Ifosfamide—testicular cancer	0.00144	0.0016	CcSEcCtD
Acetazolamide—Photosensitivity reaction—Doxorubicin—testicular cancer	0.00143	0.00159	CcSEcCtD
Acetazolamide—Hepatobiliary disease—Epirubicin—testicular cancer	0.00143	0.00159	CcSEcCtD
Acetazolamide—Feeling abnormal—Etoposide—testicular cancer	0.00142	0.00157	CcSEcCtD
Acetazolamide—Nausea—Dactinomycin—testicular cancer	0.00141	0.00157	CcSEcCtD
Acetazolamide—Agranulocytosis—Epirubicin—testicular cancer	0.00141	0.00157	CcSEcCtD
Acetazolamide—Drowsiness—Doxorubicin—testicular cancer	0.0014	0.00155	CcSEcCtD
Acetazolamide—Stevens-Johnson syndrome—Doxorubicin—testicular cancer	0.00139	0.00154	CcSEcCtD
Acetazolamide—Vomiting—Ifosfamide—testicular cancer	0.00138	0.00154	CcSEcCtD
Acetazolamide—Erythema multiforme—Methotrexate—testicular cancer	0.00137	0.00152	CcSEcCtD
Acetazolamide—Urticaria—Etoposide—testicular cancer	0.00137	0.00152	CcSEcCtD
Acetazolamide—Body temperature increased—Etoposide—testicular cancer	0.00136	0.00151	CcSEcCtD
Acetazolamide—Tinnitus—Methotrexate—testicular cancer	0.00135	0.0015	CcSEcCtD
Acetazolamide—Hypoaesthesia—Epirubicin—testicular cancer	0.00135	0.0015	CcSEcCtD
Acetazolamide—Asthenia—Cisplatin—testicular cancer	0.00135	0.00149	CcSEcCtD
Acetazolamide—Haematuria—Doxorubicin—testicular cancer	0.00133	0.00148	CcSEcCtD
Acetazolamide—Hepatobiliary disease—Doxorubicin—testicular cancer	0.00132	0.00147	CcSEcCtD
Acetazolamide—Agranulocytosis—Doxorubicin—testicular cancer	0.0013	0.00145	CcSEcCtD
Acetazolamide—Nausea—Ifosfamide—testicular cancer	0.00129	0.00144	CcSEcCtD
Acetazolamide—Diarrhoea—Cisplatin—testicular cancer	0.00128	0.00143	CcSEcCtD
Acetazolamide—Erythema multiforme—Epirubicin—testicular cancer	0.00128	0.00142	CcSEcCtD
Acetazolamide—Tinnitus—Epirubicin—testicular cancer	0.00126	0.0014	CcSEcCtD
Acetazolamide—Flushing—Epirubicin—testicular cancer	0.00126	0.0014	CcSEcCtD
Acetazolamide—Hypoaesthesia—Doxorubicin—testicular cancer	0.00125	0.00139	CcSEcCtD
Acetazolamide—Dysgeusia—Methotrexate—testicular cancer	0.00124	0.00137	CcSEcCtD
Acetazolamide—Asthenia—Etoposide—testicular cancer	0.00123	0.00137	CcSEcCtD
Acetazolamide—Vomiting—Cisplatin—testicular cancer	0.00119	0.00132	CcSEcCtD
Acetazolamide—Erythema multiforme—Doxorubicin—testicular cancer	0.00119	0.00132	CcSEcCtD
Acetazolamide—Diarrhoea—Etoposide—testicular cancer	0.00118	0.00131	CcSEcCtD
Acetazolamide—Ill-defined disorder—Methotrexate—testicular cancer	0.00117	0.0013	CcSEcCtD
Acetazolamide—Tinnitus—Doxorubicin—testicular cancer	0.00117	0.0013	CcSEcCtD
Acetazolamide—Flushing—Doxorubicin—testicular cancer	0.00116	0.00129	CcSEcCtD
Acetazolamide—Dysgeusia—Epirubicin—testicular cancer	0.00116	0.00128	CcSEcCtD
Acetazolamide—Malaise—Methotrexate—testicular cancer	0.00114	0.00126	CcSEcCtD
Acetazolamide—Dizziness—Etoposide—testicular cancer	0.00114	0.00126	CcSEcCtD
Acetazolamide—Leukopenia—Methotrexate—testicular cancer	0.00113	0.00125	CcSEcCtD
Acetazolamide—Nausea—Cisplatin—testicular cancer	0.00111	0.00124	CcSEcCtD
Acetazolamide—Ill-defined disorder—Epirubicin—testicular cancer	0.0011	0.00122	CcSEcCtD
Acetazolamide—Convulsion—Methotrexate—testicular cancer	0.00109	0.00121	CcSEcCtD
Acetazolamide—Vomiting—Etoposide—testicular cancer	0.00109	0.00121	CcSEcCtD
Acetazolamide—Agitation—Epirubicin—testicular cancer	0.00108	0.0012	CcSEcCtD
Acetazolamide—Headache—Etoposide—testicular cancer	0.00108	0.0012	CcSEcCtD
Acetazolamide—Dysgeusia—Doxorubicin—testicular cancer	0.00107	0.00119	CcSEcCtD
Acetazolamide—Malaise—Epirubicin—testicular cancer	0.00106	0.00118	CcSEcCtD
Acetazolamide—Discomfort—Methotrexate—testicular cancer	0.00106	0.00118	CcSEcCtD
Acetazolamide—Leukopenia—Epirubicin—testicular cancer	0.00106	0.00117	CcSEcCtD
Acetazolamide—Confusional state—Methotrexate—testicular cancer	0.00104	0.00115	CcSEcCtD
Acetazolamide—Anaphylactic shock—Methotrexate—testicular cancer	0.00103	0.00114	CcSEcCtD
Acetazolamide—Convulsion—Epirubicin—testicular cancer	0.00102	0.00114	CcSEcCtD
Acetazolamide—Nausea—Etoposide—testicular cancer	0.00102	0.00113	CcSEcCtD
Acetazolamide—Ill-defined disorder—Doxorubicin—testicular cancer	0.00101	0.00113	CcSEcCtD
Acetazolamide—Thrombocytopenia—Methotrexate—testicular cancer	0.00101	0.00112	CcSEcCtD
Acetazolamide—Agitation—Doxorubicin—testicular cancer	0.001	0.00111	CcSEcCtD
Acetazolamide—Discomfort—Epirubicin—testicular cancer	0.000993	0.0011	CcSEcCtD
Acetazolamide—Malaise—Doxorubicin—testicular cancer	0.000985	0.00109	CcSEcCtD
Acetazolamide—Leukopenia—Doxorubicin—testicular cancer	0.000978	0.00109	CcSEcCtD
Acetazolamide—Confusional state—Epirubicin—testicular cancer	0.000971	0.00108	CcSEcCtD
Acetazolamide—Anaphylactic shock—Epirubicin—testicular cancer	0.000963	0.00107	CcSEcCtD
Acetazolamide—Shock—Epirubicin—testicular cancer	0.000948	0.00105	CcSEcCtD
Acetazolamide—Convulsion—Doxorubicin—testicular cancer	0.000946	0.00105	CcSEcCtD
Acetazolamide—Thrombocytopenia—Epirubicin—testicular cancer	0.000943	0.00105	CcSEcCtD
Acetazolamide—Paraesthesia—Methotrexate—testicular cancer	0.000924	0.00103	CcSEcCtD
Acetazolamide—Discomfort—Doxorubicin—testicular cancer	0.000919	0.00102	CcSEcCtD
Acetazolamide—Somnolence—Methotrexate—testicular cancer	0.000915	0.00102	CcSEcCtD
Acetazolamide—Dyspepsia—Methotrexate—testicular cancer	0.000906	0.00101	CcSEcCtD
Acetazolamide—Confusional state—Doxorubicin—testicular cancer	0.000899	0.000998	CcSEcCtD
Acetazolamide—Decreased appetite—Methotrexate—testicular cancer	0.000895	0.000994	CcSEcCtD
Acetazolamide—Anaphylactic shock—Doxorubicin—testicular cancer	0.000891	0.00099	CcSEcCtD
Acetazolamide—Gastrointestinal disorder—Methotrexate—testicular cancer	0.000889	0.000987	CcSEcCtD
Acetazolamide—Fatigue—Methotrexate—testicular cancer	0.000887	0.000986	CcSEcCtD
Acetazolamide—Shock—Doxorubicin—testicular cancer	0.000877	0.000974	CcSEcCtD
Acetazolamide—Thrombocytopenia—Doxorubicin—testicular cancer	0.000873	0.000969	CcSEcCtD
Acetazolamide—Paraesthesia—Epirubicin—testicular cancer	0.000865	0.000961	CcSEcCtD
Acetazolamide—Somnolence—Epirubicin—testicular cancer	0.000856	0.000951	CcSEcCtD
Acetazolamide—Feeling abnormal—Methotrexate—testicular cancer	0.000848	0.000942	CcSEcCtD
Acetazolamide—Dyspepsia—Epirubicin—testicular cancer	0.000848	0.000942	CcSEcCtD
Acetazolamide—Decreased appetite—Epirubicin—testicular cancer	0.000837	0.00093	CcSEcCtD
Acetazolamide—Gastrointestinal disorder—Epirubicin—testicular cancer	0.000832	0.000924	CcSEcCtD
Acetazolamide—Fatigue—Epirubicin—testicular cancer	0.000831	0.000922	CcSEcCtD
Acetazolamide—Urticaria—Methotrexate—testicular cancer	0.000818	0.000908	CcSEcCtD
Acetazolamide—Body temperature increased—Methotrexate—testicular cancer	0.000814	0.000904	CcSEcCtD
Acetazolamide—Paraesthesia—Doxorubicin—testicular cancer	0.0008	0.000889	CcSEcCtD
Acetazolamide—Feeling abnormal—Epirubicin—testicular cancer	0.000794	0.000882	CcSEcCtD
Acetazolamide—Somnolence—Doxorubicin—testicular cancer	0.000792	0.00088	CcSEcCtD
Acetazolamide—Dyspepsia—Doxorubicin—testicular cancer	0.000785	0.000871	CcSEcCtD
Acetazolamide—Decreased appetite—Doxorubicin—testicular cancer	0.000775	0.000861	CcSEcCtD
Acetazolamide—Gastrointestinal disorder—Doxorubicin—testicular cancer	0.000769	0.000855	CcSEcCtD
Acetazolamide—Fatigue—Doxorubicin—testicular cancer	0.000768	0.000853	CcSEcCtD
Acetazolamide—Urticaria—Epirubicin—testicular cancer	0.000765	0.00085	CcSEcCtD
Acetazolamide—Body temperature increased—Epirubicin—testicular cancer	0.000761	0.000846	CcSEcCtD
Acetazolamide—Asthenia—Methotrexate—testicular cancer	0.000739	0.00082	CcSEcCtD
Acetazolamide—Feeling abnormal—Doxorubicin—testicular cancer	0.000734	0.000816	CcSEcCtD
Acetazolamide—Urticaria—Doxorubicin—testicular cancer	0.000708	0.000786	CcSEcCtD
Acetazolamide—Body temperature increased—Doxorubicin—testicular cancer	0.000705	0.000783	CcSEcCtD
Acetazolamide—Diarrhoea—Methotrexate—testicular cancer	0.000704	0.000782	CcSEcCtD
Acetazolamide—Asthenia—Epirubicin—testicular cancer	0.000691	0.000768	CcSEcCtD
Acetazolamide—Dizziness—Methotrexate—testicular cancer	0.000681	0.000756	CcSEcCtD
Acetazolamide—Diarrhoea—Epirubicin—testicular cancer	0.000659	0.000732	CcSEcCtD
Acetazolamide—Vomiting—Methotrexate—testicular cancer	0.000654	0.000727	CcSEcCtD
Acetazolamide—Headache—Methotrexate—testicular cancer	0.000645	0.000716	CcSEcCtD
Acetazolamide—Asthenia—Doxorubicin—testicular cancer	0.000639	0.00071	CcSEcCtD
Acetazolamide—Dizziness—Epirubicin—testicular cancer	0.000637	0.000708	CcSEcCtD
Acetazolamide—Vomiting—Epirubicin—testicular cancer	0.000612	0.00068	CcSEcCtD
Acetazolamide—Nausea—Methotrexate—testicular cancer	0.000611	0.000679	CcSEcCtD
Acetazolamide—Diarrhoea—Doxorubicin—testicular cancer	0.00061	0.000677	CcSEcCtD
Acetazolamide—Headache—Epirubicin—testicular cancer	0.000603	0.00067	CcSEcCtD
Acetazolamide—Dizziness—Doxorubicin—testicular cancer	0.000589	0.000655	CcSEcCtD
Acetazolamide—Nausea—Epirubicin—testicular cancer	0.000572	0.000636	CcSEcCtD
Acetazolamide—Vomiting—Doxorubicin—testicular cancer	0.000567	0.000629	CcSEcCtD
Acetazolamide—Headache—Doxorubicin—testicular cancer	0.000558	0.00062	CcSEcCtD
Acetazolamide—Nausea—Doxorubicin—testicular cancer	0.000529	0.000588	CcSEcCtD
